Get breaking news and analysis on Atara Biotherapeutics, Inc. (ATRA) stock, price quote and chart, trading and investing tools. category NASDAQ:SRRA, Stocks to Sell, NASDAQ:ACAD, and 3 more. from Stock Picks Hottest Manufacturing Stocks Now – RDUS ATRA RARE CMCO. November 24, 2016. Atara Biotherapeutics (NASDAQ: ATRA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers Their average twelve-month price target is $29.88, suggesting that the stock has a possible upside of 80.95%. The high price target for ATRA is $70.00 and the low price target for ATRA is $9.00. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy." Atara Biotherapeutics (NASDAQ:ATRA) Earnings Information. Atara Biotherapeutics last posted its earnings data on November 7th, 2019. The biotechnology company reported ($1.31) EPS for the quarter, topping analysts' consensus estimates of ($1.40) by $0.09. Atara Biotherapeutics has generated ($5.27) earnings per share over the last year.
Nejnovější tweety od uživatele @DayTradersDigest (@DayTradersDige1). Stocks OTC Markets Nasdaq. New York, USA
Stocks Most Active Unusual Volume 52 Week High/Low Upcoming Splits New SEC Filings IPO Summary Earnings Calendar Dividend Stocks Sector Analysis Commodities Gold Oil Analyst Activity Upgrades/Downgrades Forecast Changes Earning Surprises Summary quote, performance, and fundamental analysis for NASDAQ:ATRA Atara Biotherapeutics Inc 6/17/2019 · Astrazeneca PLC Common Stock (AZN) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Atara Biotherapeutics chart and ATRA price. Free real-time prices, trades and chat. Atara Biotherapeutics (ATRA) stock price, charts, trades & the US's most popular discussion forums. Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus
A Agilent Technologies, Inc. 2019/11/25 AA Alcoa Corp 2019/10/16 Aaalf Aareal Bank, Inc. (Aaalf) 2019/11/12 AAC AAC Holdings, Inc (Nasdaq: AAC ) 2019/08/30 Aaigf AIA Group Limited (Aaigf) 2019/08/22 AAL American Airlines Group 2019/10/24…
11/8/2019 · Atara Biotherapeutics (NASDAQ: ATRA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Which company executives are buying and selling shares of Atara Biotherapeutics (NASDAQ:ATRA) stock? View the most recent insider trading activity for ATRA stock at Are you researching Atara Biotherapeutics (NASDAQ:ATRA) stock for your portfolio? View ATRA's latest 10K form and other filings with the Securities and Exchange
Earnings Per Share Expected for Editas Medicine This at AMRounds Report Aimmune Gaining Momentum While Experiences Significant Insider AMAdverum Assessing The Strong Prospects Of Gene Therapy AMEditas Director Buys . Company Profile…
Stock Performance NASDAQ:ATRA Stock Symbol ATRA Stock Exchange NASDAQ IPO Date Oct 7, 2014 Amount Raised $55M Share Price at IPO $11.00 The company was founded in 2012, and since 2014 the company's stock has been publicly traded on Nasdaq under the symbol ATRA. Atara's most advanced View Atara Biotherapeutics, Inc. ATRA investment & stock information. Get the latest Atara Biotherapeutics, Inc. ATRA detailed stock quotes, stock data,
Tens of thousands of American seniors, already struggling on fixed incomes that have been stagnant for years, are at risk to increases in their annual life insurance premiums they cannot afford to pay, according to a number of speakers this…
Atara Biotherapeutics, Inc. (ATRA) Options Chain - Get free stock options quotes including option chains with call and put prices, viewable by expiration date, most
On Thursday morning, 189 companies achieved new lows for the year. Interesting Highlights: Pfizer (NYSE: PFE) was the biggest company in terms Afya Ltd. (Nasdaq: AFYA) surged 26.8% to close at $24.09.